• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Galderma Aesthetics CA positions





All of the directors have signed NDA’s. They’ll all be getting over 7 figures if and when a buyout occurs. They have major incentive to say everything is great and tell the word Galderma is amazing. It’s all about the Benjamin’s. Reps and managers quitting and hitting numbers are meaningless. When they sell this rat nest to some dumb company for billions is when the directors get their payday.